BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2868631)

  • 1. In vitro activity of the trypanocidal diamidine DAPI on animal-infective Trypanosoma brucei brucei.
    Borowy NK; Fink E; Hirumi H
    Acta Trop; 1985 Dec; 42(4):287-98. PubMed ID: 2868631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assay for screening drugs against animal-infective bloodstream forms of Trypanosoma brucei brucei in vitro.
    Borowy NK; Hirumi H; Waithaka HK; Mkoji G
    Drugs Exp Clin Res; 1985; 11(3):155-61. PubMed ID: 3836123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Merschjohann K; Steverding D
    Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.
    Kubata BK; Nagamune K; Murakami N; Merkel P; Kabututu Z; Martin SK; Kalulu TM; Huq M; Yoshida M; Ohnishi-Kameyama M; Kinoshita T; Duszenko M; Urade Y
    Int J Parasitol; 2005 Jan; 35(1):91-103. PubMed ID: 15619520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma brucei: effects of methoprene and other isoprenoid compounds on procyclic and bloodstream forms in vitro and in mice.
    Harmon MA; Scott TC; Li Y; Boehm MF; Phillips MA; Mangelsdorf DJ
    Exp Parasitol; 1997 Nov; 87(3):229-36. PubMed ID: 9371088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-phe-ala-CHN2.
    Scory S; Caffrey CR; Stierhof YD; Ruppel A; Steverding D
    Exp Parasitol; 1999 Apr; 91(4):327-33. PubMed ID: 10092476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in recent isolates of Trypanosoma brucei and Trypanosoma congolense.
    Joshua RA
    Rev Elev Med Vet Pays Trop; 1988; 41(4):359-64. PubMed ID: 3253857
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro and in vivo effects of metronidazole and chloroquine on Trypanosoma brucei brucei.
    Otigbuo IN; Woo PT
    J Parasitol; 1988 Apr; 74(2):201-6. PubMed ID: 3357110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dipalmitoylphosphatidylcholine liposome against African trypanosomes.
    Kuboki N; Yokoyama N; Kojima N; Sakurai T; Inoue N; Sugimoto C
    J Parasitol; 2006 Apr; 92(2):389-93. PubMed ID: 16729700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei: five commonly used trypanocides assayed in vitro with a mammalian feeder layer system for cultivation of bloodstream forms.
    Borowy NK; Fink E; Hirumi H
    Exp Parasitol; 1985 Dec; 60(3):323-30. PubMed ID: 4076388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
    Papagiannaros A; Bories C; Demetzos C; Loiseau PM
    Biomed Pharmacother; 2005 Dec; 59(10):545-50. PubMed ID: 16325367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitrypanosomal activity of phosphonylmethoxyalkylpurines.
    Kaminsky R; Zweygarth E; De Clercq E
    J Parasitol; 1994 Dec; 80(6):1026-30. PubMed ID: 7799144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei.
    Troeberg L; Morty RE; Pike RN; Lonsdale-Eccles JD; Palmer JT; McKerrow JH; Coetzer TH
    Exp Parasitol; 1999 Apr; 91(4):349-55. PubMed ID: 10092479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
    Mutomba MC; Li F; Gottesdiener KM; Wang CC
    Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
    Kaminsky R; Zweygarth E
    J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
    Ott R; Chibale K; Anderson S; Chipeleme A; Chaudhuri M; Guerrah A; Colowick N; Hill GC
    Acta Trop; 2006 Dec; 100(3):172-84. PubMed ID: 17126803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo effects of mefloquine on Trypanosoma brucei brucei.
    Otigbuo IN; Onabanjo AO
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(2):191-9. PubMed ID: 1512455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.